BR9813797A - Processo para tratar glaucoma de glc1a, e, composição para controlar glaucoma de glc1a. - Google Patents

Processo para tratar glaucoma de glc1a, e, composição para controlar glaucoma de glc1a.

Info

Publication number
BR9813797A
BR9813797A BR9813797-2A BR9813797A BR9813797A BR 9813797 A BR9813797 A BR 9813797A BR 9813797 A BR9813797 A BR 9813797A BR 9813797 A BR9813797 A BR 9813797A
Authority
BR
Brazil
Prior art keywords
glc1a glaucoma
glaucoma
glc1a
treating
composition
Prior art date
Application number
BR9813797-2A
Other languages
English (en)
Inventor
Abbot F Clark
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of BR9813797A publication Critical patent/BR9813797A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PROCESSO PARA TRATAR GLAUCOMA DE GLC1A, E USO DE UM ANTAGONISTA DE GLUCOCORTICóIDE NãO-ESTERóIDE" Descreve-se composições de antagonistas de glucocorticóides não-esteróides para tratar glaucoma de GLC1A, e processos para sua utilização.
BR9813797-2A 1997-12-19 1998-12-07 Processo para tratar glaucoma de glc1a, e, composição para controlar glaucoma de glc1a. BR9813797A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/994,957 US6051573A (en) 1994-06-28 1997-12-19 Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists
PCT/US1998/025914 WO1999032101A1 (en) 1997-12-19 1998-12-07 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists

Publications (1)

Publication Number Publication Date
BR9813797A true BR9813797A (pt) 2000-10-03

Family

ID=25541259

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813797-2A BR9813797A (pt) 1997-12-19 1998-12-07 Processo para tratar glaucoma de glc1a, e, composição para controlar glaucoma de glc1a.

Country Status (7)

Country Link
US (1) US6051573A (pt)
EP (1) EP1047410A1 (pt)
JP (1) JP2001526216A (pt)
AU (1) AU733645B2 (pt)
BR (1) BR9813797A (pt)
CA (1) CA2313232A1 (pt)
WO (1) WO1999032101A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4676061B2 (ja) * 1998-07-30 2011-04-27 アボット・ラボラトリーズ グルココルチコイド選択性薬剤
US6166013A (en) * 1998-07-30 2000-12-26 Abbott Laboratories Glucocortiocoid-selective agents
AU2001216038A1 (en) * 2000-11-14 2002-05-27 Alcon Laboratories Inc. Treatment of glaucoma and ocular hypertension
EP1353674A1 (en) * 2000-12-29 2003-10-22 Alteon, Inc. Method for treating glaucoma ivb
US7119112B2 (en) 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
GB0601092D0 (en) * 2006-01-19 2006-03-01 Daniolabs Ltd The Prevention Of Systemic Side-Effects Of Glucocorticoids
WO2007120574A2 (en) 2006-04-11 2007-10-25 Merck & Co., Inc. Diaryl substituted alkanes
WO2008030369A1 (en) * 2006-09-01 2008-03-13 Merck & Co., Inc. Inhibitors of 5 -lipoxygenase activating protein ( flap)
JP2015093869A (ja) * 2013-11-14 2015-05-18 国立大学法人東北大学 網膜保護薬剤、及び網膜疾患治療用徐放デバイス
AU2016226451B2 (en) 2015-03-02 2019-12-19 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonist and somatostatin analogues to treat ACTH-secreting tumors
US10610534B2 (en) 2015-03-30 2020-04-07 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
US9829495B2 (en) 2015-08-13 2017-11-28 Corcept Therapeutics, Inc. Method for differentially diagnosing ACTH-dependent Cushing's syndrome
MX2018008849A (es) 2016-01-19 2019-01-31 Corcept Therapeutics Inc Diagnostico diferencial de sindrome de cushing ectopico.
US11213526B2 (en) 2017-06-20 2022-01-04 Corcept Therapeutics, Inc. Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
JP2024500748A (ja) 2020-12-18 2024-01-10 インスティル バイオ （ユーケイ） リミテッド 腫瘍浸潤リンパ球の処理
CN115806525B (zh) * 2023-02-06 2023-05-23 深圳湾实验室 一种合成α-三芳基胺的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296206A (en) * 1980-04-30 1981-10-20 United States Of America Irreversible anti-glucocorticoids
US4395404A (en) * 1982-05-14 1983-07-26 George Washington University Synthetic thymosin β3 and β4 analogues
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
GB9014221D0 (en) * 1990-06-26 1990-08-15 Janssen Pharmaceutica Nv Method of treating alopecia
JPH068691B2 (ja) * 1990-12-14 1994-02-02 エイチ・イー・シー株式会社 エアクリーナ付きストーブ
US5512591A (en) * 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
US5606043A (en) * 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma

Also Published As

Publication number Publication date
CA2313232A1 (en) 1999-07-01
EP1047410A1 (en) 2000-11-02
JP2001526216A (ja) 2001-12-18
AU1714399A (en) 1999-07-12
WO1999032101A1 (en) 1999-07-01
AU733645B2 (en) 2001-05-17
US6051573A (en) 2000-04-18

Similar Documents

Publication Publication Date Title
BR9813797A (pt) Processo para tratar glaucoma de glc1a, e, composição para controlar glaucoma de glc1a.
BR9813684A (pt) Processo para tratar o glaucoma glc1a, e, composição para controlar o glaucoma glc1a.
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
BR9916307A (pt) Derivados quinolina
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
BR9609467A (pt) Composto uso de um composto composição farmacéutica e processos para preparação de um composto e tratamento de distúrbios de agregação planquetária
BR0007556A (pt) Antagonistas de tweak e de receptor de tweak e uso dos mesmos para tratar distúrbios imunológicos
BR9407924A (pt) Corpo revestido processo para sua fabricaçao assim como emprego do mesmo
BR9810991A (pt) Novos compostos
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
BR9913800A (pt) Método para tratar glaucoma, e, composição para tratar glaucoma
CO4940465A1 (es) Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3- il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona
BR9907788A (pt) Agentes antiinflamatórios seletivos paraglicocorticóides
BR9914925A (pt) Processos para reduzir o crescimento de cabelo de mamìfero, para tratar uma área de pele, e, para produzir uma composição para inibir crescimento do cabelo de mamìfero, uso de um inibidor de fosfatase alcalina, e, composição usada para inibir crescimento de cabelo de mamìfero.
BR9507073A (pt) Composto processos para preparar o mesmo e para tratar uma doença no sistema nervoso central composiçao farmacêutica e uso do composto
BR9907847A (pt) Agentes anti-inflamatórios seletivos para glucocorticóides
ATE303362T1 (de) Chalcon-derivate mit antiproliferativer aktivität
DE60210101D1 (de) Behandlung von haarfollikeln mit neurokinin 1 rezeptor antagonisten
BR9901058A (pt) N-cail e n-aroil aralquil amidas.
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
BR9508406A (pt) Uso de um composto e método para o tratamento e/ou profilaxia em mamíferos
ATE348604T1 (de) Agonisten und antagonisten der nicotinergen acetylcholinrezeptoren von insekten als endoparasitizide
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
BR9808923A (pt) Composto, e, processo para fazer o mesmo

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]